115 related articles for article (PubMed ID: 3620498)
21. Rapid purification of factor IX, factor X and prothrombin by immunoaffinity and ion exchange chromatography.
Ahmad SS; Rawala-Sheikh R; Thompson AR; Walsh PN
Thromb Res; 1989 Jul; 55(1):121-33. PubMed ID: 2781515
[TBL] [Abstract][Full Text] [Related]
22. The high affinity calcium-binding site involved in protein C activation is outside the first epidermal growth factor homology domain.
Rezaie AR; Esmon NL; Esmon CT
J Biol Chem; 1992 Jun; 267(17):11701-4. PubMed ID: 1601845
[TBL] [Abstract][Full Text] [Related]
23. Regulation of the tertiary structure and function of coagulation factor IX by magnesium (II) ions.
Sekiya F; Yamashita T; Atoda H; Komiyama Y; Morita T
J Biol Chem; 1995 Jun; 270(24):14325-31. PubMed ID: 7782291
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of Mg2+- and Ca2+-bound Gla domain of factor IX complexed with binding protein.
Shikamoto Y; Morita T; Fujimoto Z; Mizuno H
J Biol Chem; 2003 Jun; 278(26):24090-4. PubMed ID: 12695512
[TBL] [Abstract][Full Text] [Related]
25. Crystal structure of the calcium-stabilized human factor IX Gla domain bound to a conformation-specific anti-factor IX antibody.
Huang M; Furie BC; Furie B
J Biol Chem; 2004 Apr; 279(14):14338-46. PubMed ID: 14722079
[TBL] [Abstract][Full Text] [Related]
26. Anti-human factor IX monoclonal antibodies specific for calcium ion-induced conformations.
Sugo T; Mizuguchi J; Kamikubo Y; Matsuda M
Thromb Res; 1990 Jun; 58(6):603-14. PubMed ID: 2385830
[TBL] [Abstract][Full Text] [Related]
27. Factor IX Zutphen: a Cys18-->Arg mutation results in formation of a heterodimer with alpha 1-microglobulin and the inability to form a calcium-induced conformation.
Wojcik EG; van den Berg M; van der Linden IK; Poort SR; Cupers R; Bertina RM
Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):753-9. PubMed ID: 7487929
[TBL] [Abstract][Full Text] [Related]
28. Localization of the specific binding site for magnesium(II) ions in factor IX.
Sekiya F; Yoshida M; Yamashita T; Morita T
FEBS Lett; 1996 Sep; 392(3):205-8. PubMed ID: 8774845
[TBL] [Abstract][Full Text] [Related]
29. Functional consequences of mutations in amino acid residues that stabilize calcium binding to the first epidermal growth factor homology domain of human protein C.
Geng JP; Cheng CH; Castellino FJ
Thromb Haemost; 1996 Nov; 76(5):720-8. PubMed ID: 8950780
[TBL] [Abstract][Full Text] [Related]
30. Binding of calcium to individual gamma-carboxyglutamic acid residues of human protein C.
Colpitts TL; Prorok M; Castellino FJ
Biochemistry; 1995 Feb; 34(8):2424-30. PubMed ID: 7873521
[TBL] [Abstract][Full Text] [Related]
31. Characterization of gamma-carboxyglutamic acid residue 21 of human factor IX.
Wolberg AS; Li L; Cheung WF; Hamaguchi N; Pedersen LG; Stafford DW
Biochemistry; 1996 Aug; 35(32):10321-7. PubMed ID: 8756687
[TBL] [Abstract][Full Text] [Related]
32. Purification of six human vitamin K-dependent proteins in a single chromatographic step using immunoaffinity columns.
Jenny R; Church W; Odegaard B; Litwiller R; Mann K
Prep Biochem; 1986; 16(3):227-45. PubMed ID: 3748998
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibodies to avian lipoprotein lipase. Purification of the enzyme by immunoaffinity chromatography.
Gershenwald JE; Bensadoun A; Saluja A
Biochim Biophys Acta; 1985 Oct; 836(3):286-95. PubMed ID: 4041471
[TBL] [Abstract][Full Text] [Related]
34. Highly conserved residue arginine-15 is required for the Ca2+-dependent properties of the gamma-carboxyglutamic acid domain of human anticoagulation protein C and activated protein C.
Thariath A; Castellino FJ
Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):309-15. PubMed ID: 9078278
[TBL] [Abstract][Full Text] [Related]
35. Calcium-dependent interaction between the epidermal growth factor precursor-like region of human protein C and a monoclonal antibody.
Ohlin AK; Stenflo J
J Biol Chem; 1987 Oct; 262(28):13798-804. PubMed ID: 2443497
[TBL] [Abstract][Full Text] [Related]
36. gamma-Carboxyglutamic acids 36 and 40 do not contribute to human factor IX function.
Gillis S; Furie BC; Furie B; Patel H; Huberty MC; Switzer M; Foster WB; Scoble HA; Bond MD
Protein Sci; 1997 Jan; 6(1):185-96. PubMed ID: 9007991
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of CNBr, FMP and hydrazide resins for immunoaffinity purification of factor IX.
Highsmith F; Regan T; Clark D; Drohan W; Tharakan J
Biotechniques; 1992 Mar; 12(3):418-23. PubMed ID: 1571154
[TBL] [Abstract][Full Text] [Related]
38. Characterization of human thyroid peroxidase purified by monoclonal antibody-assisted chromatography.
Ohtaki S; Kotani T; Nakamura Y
J Clin Endocrinol Metab; 1986 Sep; 63(3):570-6. PubMed ID: 3016020
[TBL] [Abstract][Full Text] [Related]
39. Characterization of monoclonal antibodies against human protein C specific for the calcium ion-induced conformation or for the activation peptide region.
Laurell M; Ikeda K; Lindgren S; Stenflo J
FEBS Lett; 1985 Oct; 191(1):75-81. PubMed ID: 3932093
[TBL] [Abstract][Full Text] [Related]
40. Properties of a recombinant chimeric protein in which the gamma-carboxyglutamic acid and helical stack domains of human anticoagulant protein C are replaced by those of human coagulation factor VII.
Geng JP; Castellino FJ
Thromb Haemost; 1997 May; 77(5):926-33. PubMed ID: 9184404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
